2006Elsevier eBooksRequires access

Osteoporosis : best practice & research compendium

Cyrus Cooper, Anthony D. Woolf

Open publisher page 2 citations

Abstract

Contents: Epidemiology of osteoporosis Fractures in the elderly: epidemiology and demography Pathogenesis of osteoporosis Prenatal and childhood influences on osteoporosis Corticosteroid osteoporosis Lower peak bone mass and its decline The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk The use of bone densitometry in clinical practice Role of biochemical markers in the management of osteoporosis Glucocorticoid-induced osteoporosis Osteoporosis in men Osteoporosis in childhood diseases: prevention and therapy Post-menopausal osteoporosis How to prevent fractures in the individual with osteoporosis Non-pharmacological interventions Phyto-oestrogens Oestrogen and selective receptor modulators (SERMS): current roles in the prevention and treatment of osteoporosis Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis Biologic therapies in osteoporosis Anabolic bone binding treatment [PTH] analogues and strontium Cost utility of treatment of osteoporosis Risk assessment in osteoporosis Future methods in the assessment of bone mass and structure

About this research paper

What this paper is about

Contents: Epidemiology of osteoporosis Fractures in the elderly: epidemiology and demography Pathogenesis of osteoporosis Prenatal and childhood influences on osteoporosis Corticosteroid osteoporosis Lower peak bone mass and its decline The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk The use of bone densitometry in clinical practice Role of biochemical markers in the management of osteoporosis Glucocorticoid-induced osteoporosis Osteoporosis in men Osteoporosis in childhood diseases: prevention and therapy Post-menopausal osteoporosis How to prevent fractures in the individual with osteoporosis Non-pharmacological interventions Phyto-oestrogens Oestrogen and selective receptor modulators (SERMS): current roles in the prevention and treatment of osteoporosis Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis Biologic therapies in osteoporosis Anabolic bone binding treatment [PTH] analogues and strontium Cost utility of treatment of osteoporosis Risk assessment in osteoporosis Future methods in the assessment of bone mass and structure

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Contents: Epidemiology of osteoporosis Fractures in the elderly: epidemiology and demography Pathogenesis of osteoporosis Prenatal and childhood influences on osteoporosis Corticosteroid osteoporosis Lower peak bone mass and its decline The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk The use of bone densitometry in clinical practice Role of biochemical markers in the management of osteoporosis Glucocorticoid-induced osteoporosis Osteoporosis in men Osteoporosis in childhood diseases: prevention and therapy Post-menopausal osteoporosis How to prevent fractures in the individual with osteoporosis Non-pharmacological interventions Phyto-oestrogens Oestrogen and selective receptor modulators (SERMS): current roles in the prevention and treatment of osteoporosis Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis Biologic therapies in osteoporosis Anabolic bone binding treatment [PTH] analogues and strontium Cost utility of treatment of osteoporosis Risk assessment in osteoporosis Future methods in the assessment of bone mass and structure

Key concepts: Osteoporosis, Medicine, Internal medicine, Calcitonin, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Osteoporosis : best practice & research compendium — Research Paper | ScholarLens